ChemicalBook >> CAS DataBase List >>2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE

2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE

CAS No.
61001-06-7
Chemical Name:
2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE
Synonyms
AKOS BC-1853;2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE;Imidazo[2,1-a]isoquinoline, 2-(4-bromophenyl)-
CBNumber:
CB9418891
Molecular Formula:
C17H11BrN2
Molecular Weight:
323.19
MDL Number:
MFCD01721881
MOL File:
Mol file
Last updated:2022-12-21 16:56:50

2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE Properties

FDA UNII L2EF3V5QU3

2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
American Custom Chemicals Corporation HCH0173782 2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE 95.00% 61001-06-7 5MG $500.24 2021-12-16 Buy
Product number Packaging Price Buy
HCH0173782 5MG $500.24 Buy

2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE Chemical Properties,Uses,Production

Hazard

A reproductive hazard.

2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE Preparation Products And Raw materials

Raw materials

Preparation Products

2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE Suppliers

Global( 3)Suppliers
Supplier Tel Email Country ProdList Advantage
Interbioscreen Ltd. -- screen@ibscreen.chg.ru Finland 6176 60
Specs -- info@specs.net The Netherlands 6833 70
AKos Consulting & Solutions GmbH -- akos@akosgmbh.de Germany 6717 72

61001-06-7(2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE)Related Search:

AKOS BC-1853 2-(4-BROMOPHENYL)IMIDAZO[2,1-A]ISOQUINOLINE Imidazo[2,1-a]isoquinoline, 2-(4-bromophenyl)- 61001-06-7 C17H11BrN2
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept